These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 23580402)

  • 1. Age-related macular degeneration.
    Cheung LK; Eaton A
    Pharmacotherapy; 2013 Aug; 33(8):838-55. PubMed ID: 23580402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic therapy for early treatment of age-related macular degeneration].
    Fehér J; Kovács B; Kovács I; Schvöller M; Corrado Balacco G
    Orv Hetil; 2007 Dec; 148(48):2259-68. PubMed ID: 18039616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye Conditions in Older Adults: Age-Related Macular Degeneration.
    Iroku-Malize T; Kirsch S
    FP Essent; 2016 Jun; 445():24-8. PubMed ID: 27348529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age related macular degeneration].
    Helgadóttir G; Jónasson F; Sigurdsson H; Magnússon KP; Stefánsson E
    Laeknabladid; 2006 Oct; 92(10):685-96. PubMed ID: 17062902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
    Wickremasinghe SS; Michalova K; Gilhotra J; Guymer RH; Harper CA; Wong TY; Qureshi S
    Ophthalmology; 2008 Nov; 115(11):1911-5. PubMed ID: 18672291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of nutrient actions on age-related macular degeneration.
    Zampatti S; Ricci F; Cusumano A; Marsella LT; Novelli G; Giardina E
    Nutr Res; 2014 Feb; 34(2):95-105. PubMed ID: 24461310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary intake of antioxidants and risk of age-related macular degeneration.
    van Leeuwen R; Boekhoorn S; Vingerling JR; Witteman JC; Klaver CC; Hofman A; de Jong PT
    JAMA; 2005 Dec; 294(24):3101-7. PubMed ID: 16380590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapeutic approaches in neovascular age-related macular degeneration.
    Nguyen DH; Luo J; Zhang K; Zhang M
    Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N; Damico L; Shams N; Lowman H; Kim R
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.
    El-Mollayess GM; Noureddine BN; Bashshur ZF
    Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
    Koss MJ; Scholtz S; Haeussler-Sinangin Y; Singh P; Koch FH
    Ophthalmologica; 2010; 224(2):72-8. PubMed ID: 19707030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.